Health informatics

DLH to Provide Information Technology Services to the National Cancer Institute

Retrieved on: 
Thursday, March 7, 2024

NCI, the largest institute under NIH, is the federal government's principal agency for cancer research, training, and health information dissemination.

Key Points: 
  • NCI, the largest institute under NIH, is the federal government's principal agency for cancer research, training, and health information dissemination.
  • “This new award extends DLH’s longstanding partnership with NCI’s Center for Biomedical Informatics and Information Technology (“CBIIT”) by providing scientific computing and informatics to support NCI’s research mission,” said Zach Parker, President and Chief Executive Officer of DLH.
  • The contract was competitively awarded through the multiple-award blanket purchase agreement with CBIIT that the Company announced in February 2023.
  • Through this work, DLH will provide IT services for nearly 7,000 NCI employees, on matters ranging from hardware configuration to software management strategies, ServiceNow functions, network connectivity, desktop data protection, desktop platform engineering, technology refresh, and more.

Wolters Kluwer experts explore Clinical GenAI and analytics solutions at HIMSS24

Retrieved on: 
Tuesday, March 5, 2024

Experts from Wolters Kluwer Health will be at HIMSS24 leading discussions on how advanced, integrated healthcare innovations are helping healthcare organizations deliver the best patient care around the world.

Key Points: 
  • Experts from Wolters Kluwer Health will be at HIMSS24 leading discussions on how advanced, integrated healthcare innovations are helping healthcare organizations deliver the best patient care around the world.
  • Visitors to booth #2927 will see demonstrations of how Wolters Kluwer Health is helping healthcare organizations drive better outcomes in healthcare through market leading clinical decision support, patient engagement, and drug referential solutions.
  • Learn how UpToDate’s approach to Clinical GenAI prioritizes quality, safety, and transparency with AI Labs.
  • Clinical GenAI can help improve and streamline clinical decision making at the point of care, reduce clinician burnout, and support healthcare organizations to help them deliver better patient outcomes and quality performance.

HPV's Hidden Hand: New Study by Pusan National University Scientists Reveals Key Details in Head and Neck Cancer Microenvironment

Retrieved on: 
Wednesday, February 28, 2024

BUSAN, South Korea, Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects the mucous membranes of the mouth, nose, and throat. HNSCC is typically associated with tobacco exposure, alcohol abuse, and viral infections. The links between human papillomavirus (HPV) infection status and the molecular characteristics of HNSCC are not clearly defined.

Key Points: 
  • BUSAN, South Korea, Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects the mucous membranes of the mouth, nose, and throat.
  • The links between human papillomavirus (HPV) infection status and the molecular characteristics of HNSCC are not clearly defined.
  • Therefore, the HPV infection could be considered a criterion for developing treatment strategies, thereby enabling precision medicine tailored to the patient's condition!
  • Title of original paper: Deciphering Head and Neck Cancer Microenvironment: Single–Cell and Spatial Transcriptomics Reveals Human Papillomavirus–Associated Differences

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Retrieved on: 
Tuesday, February 27, 2024

NEW HAVEN, Conn., Feb. 26, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

Key Points: 
  • Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities.
  • The program works to increase awareness of clinical trials, address misinformation and historical mistrust, while ensuring the trial is easily accessible.
  • The EQBMED partnership meets sites where they are, building on their strengths and capabilities to become sustainable within the clinical trial ecosystem.
  • "EQBMED is making real progress towards equitable access to clinical trials and enhancing these sites with needed resources."

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Retrieved on: 
Monday, February 26, 2024

NEW HAVEN, Conn., Feb. 26, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

Key Points: 
  • Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities.
  • The program works to increase awareness of clinical trials, address misinformation and historical mistrust, while ensuring the trial is easily accessible.
  • The EQBMED partnership meets sites where they are, building on their strengths and capabilities to become sustainable within the clinical trial ecosystem.
  • "EQBMED is making real progress towards equitable access to clinical trials and enhancing these sites with needed resources."

Health Tech Academy Launches Bootcamp for Aspiring Healthcare IT Experts

Retrieved on: 
Monday, February 26, 2024

AUSTIN, Texas, Feb. 26, 2024 /PRNewswire-PRWeb/ -- Health Tech Academy has released its online Healthcare Information Technology bootcamp program for the next generation of aspiring healthcare professionals. The healthcare IT curriculum is designed to develop skills, competencies and certification prep. It is offered through an innovative education model where self-paced learning is combined with group coaching, mobile learning, individual coaching, social learning and career readiness support. Students only need a high school diploma/GED and reliable internet access to quickly adopt skills in electronic health record (EHS) systems, medical imaging technology, patient management systems, and other healthcare software solutions.

Key Points: 
  • AUSTIN, Texas, Feb. 26, 2024 /PRNewswire-PRWeb/ -- Health Tech Academy has released its online Healthcare Information Technology bootcamp program for the next generation of aspiring healthcare professionals.
  • "Our Healthcare IT bootcamp delivers streamlined education fundamentals that greatly improve student career prospects," said Health Tech Academy Product Manager, Danish Khan.
  • Health Tech Academy (HTA) launched its Healthcare IT program to address the anticipated need for thousands of promising health information technologists and medical registrar careers.
  • "Our Healthcare IT bootcamp delivers streamlined education fundamentals that greatly improve student career prospects," said Health Tech Academy Product Manager, Danish Khan.

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Retrieved on: 
Monday, February 26, 2024

NEW HAVEN, Conn., Feb. 26, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

Key Points: 
  • Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities.
  • The program works to increase awareness of clinical trials, address misinformation and historical mistrust, while ensuring the trial is easily accessible.
  • The EQBMED partnership meets sites where they are, building on their strengths and capabilities to become sustainable within the clinical trial ecosystem.
  • "EQBMED is making real progress towards equitable access to clinical trials and enhancing these sites with needed resources."

Nabla Appoints Clinical Leader Dr. Ed Lee as its Chief Medical Officer

Retrieved on: 
Thursday, February 8, 2024

Bringing 20 years of clinical and operational leadership experience, Dr. Lee will help drive Nabla's product vision and development

Key Points: 
  • Bringing 20 years of clinical and operational leadership experience, Dr. Lee will help drive Nabla's product vision and development
    BOSTON, Feb. 8, 2024 /PRNewswire/ -- Nabla , the leading ambient AI assistant for practitioners, today announced the appointment of Ed Lee, MD, MPH , as Chief Medical Officer.
  • He brings his expansive clinical expertise, executive experience, and Nabla Copilot implementation insights to the company to help refine and enhance the product and deployment strategy.
  • As Chief Medical Officer, Dr. Lee will be instrumental in shaping Copilot's clinical strategy and product roadmap, including RCM optimization, and he will provide feature refinement and enhancement recommendations to solidify Nabla as a leader in healthcare ambient AI.
  • He will also represent Nabla at the American Medical Informatics Association (AMIA), offering insights on the field of clinical informatics and contributing to AMIA policy responses.

KLAS Research Names Relatient Best in KLAS for Patient Self-scheduling

Retrieved on: 
Wednesday, February 7, 2024

1 Best in KLAS patient self-scheduling solution by KLAS Research.

Key Points: 
  • 1 Best in KLAS patient self-scheduling solution by KLAS Research.
  • The Best in KLAS rankings are a direct result of feedback from thousands of providers throughout 2023.
  • 2024 marks the first year that KLAS has included the category of Patient Self-Scheduling in its rankings.
  • We’re thrilled to achieve this honor.”
    The Best in KLAS report is an annual award program recognizing software and service companies that excel in helping healthcare professionals improve patient care.

MEDITECH to Showcase What Makes Expanse the Intelligent EHR at HIMSS 2024

Retrieved on: 
Thursday, February 1, 2024

Join MEDITECH at HIMSS 2024 , March 11-15 in Orlando, FL, for a comprehensive look at Expanse , the foundational EHR and cornerstone to a collaborative ecosystem.

Key Points: 
  • Join MEDITECH at HIMSS 2024 , March 11-15 in Orlando, FL, for a comprehensive look at Expanse , the foundational EHR and cornerstone to a collaborative ecosystem.
  • MEDITECH executives and product experts will also be showcasing many of the solutions that make MEDITECH the intelligent EHR, including our approach to AI , innovative care models , precision medicine , population health , interoperability , and more.
  • You can also learn about our latest advancements, including Expanse Pathology , ambient listening, and our cloud-based patient portal.
  • Visit MEDITECH’s HIMSS 2024 event page for the latest updates and additional information, including session times and a special customer appreciation event.